MATTHEW CITRON, D.O.
Glaucoma Specialist (Ophthalmology) Physician in SOUTHFIELD, Michigan. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: MATTHEW CITRON, D.O. reported a CMS MIPS final score of 100 out of 100, above the 83.1 national average, and filed 10,388 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
MATTHEW CITRON, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
MATTHEW CITRON, D.O. at a glance
High performer (top quartile)Primary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Michigan
How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Michigan providers
Glaucoma Specialist (Ophthalmology) Physician share within Michigan
Glaucoma Specialist (Ophthalmology) Physician is one of the more visible NUCC categories in Michigan
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
MATTHEW CITRON, D.O.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average
- MIPS Final Score
- 100/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) — 100/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Specialty volume Glaucoma Specialist (Ophthalmology) Physician US NPIs
100/100 MIPS final score — 16.9 pts above the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Glaucoma Specialist (Ophthalmology) Physician. Quality dim: 100.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
MATTHEW CITRON, D.O. is a Glaucoma Specialist (Ophthalmology) Physician provider practicing in SOUTHFIELD, Michigan, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1942258306. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
MATTHEW CITRON, D.O. appears in the CMS NPPES registry as a Glaucoma Specialist (Ophthalmology) Physician provider holding D.O. credentials at 29201 TELEGRAPH RD, SOUTHFIELD, MI, 48034, with a listed phone of (248) 356-0098. NPI 1942258306 was issued on 05/05/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what CITRON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 10,388 prescription claims written by this provider, covering 1,668 Medicare beneficiaries and totaling roughly $683K in drug spend, split 24% brand-name and 76% generic by claim count, with an opioid prescribing rate of 0.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.
Glaucoma Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 354 enrolled providers across 42 states and an average of 2,962 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1942258306 |
|---|---|
| Specialty | Glaucoma Specialist (Ophthalmology) Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 05/05/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm MATTHEW CITRON, D.O.'s current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where MATTHEW CITRON, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MATTHEW CITRON, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$604
Largest payer
Sight Sciences, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Michigan MI-BOM 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 — they are NOT specific to MATTHEW CITRON, D.O.. To verify MATTHEW CITRON, D.O.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
24% brand-name claims vs 76% generic, on 10,388 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 19,670
- Total Day Supply
- 570,541
- Brand vs Generic
- 24% brand / 76% generic
- Brand Drug Cost
- $445K
- Generic Drug Cost
- $238K
- Opioid Claims
- 14 (0.1% rate)
Patient Demographics
- Average Patient Age
- 74.6 years
- Avg HCC Risk Score
- 1.27
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 125, 65-74: 727, 75-84: 587, 85+: 229
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Latanoprost | 3,687 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 1,484 |
| Brimonidine Tartrate | 1,129 |
| Timolol Maleate | 913 |
| Prednisolone Acetate | 708 |
| Dorzolamide Hcl | 259 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 179 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 178 |
| Ofloxacin | 160 |
| Lumigan Bimatoprost | 142 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Glaucoma Specialist (Ophthalmology) Physician Overview
How MATTHEW CITRON, D.O. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.
MATTHEW CITRON, D.O.'s 10,388 claims are above the specialty average of 2,962.
Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as CITRON.
Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Michigan
Frequently Asked Questions
What is MATTHEW CITRON, D.O.'s specialty? ▼
How much does MATTHEW CITRON, D.O. prescribe under Medicare Part D? ▼
What is MATTHEW CITRON, D.O.'s Medicare quality score? ▼
Where is MATTHEW CITRON, D.O. located? ▼
What is MATTHEW CITRON, D.O.'s NPI number? ▼
Does MATTHEW CITRON, D.O. prescribe more brand-name or generic drugs? ▼
Does MATTHEW CITRON, D.O. prescribe opioids? ▼
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US? ▼
What drugs does MATTHEW CITRON, D.O. prescribe most often? ▼
Does MATTHEW CITRON, D.O. accept Medicare? ▼
How can I verify MATTHEW CITRON, D.O.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology